NEXAVAR (sorafenib) for Unresectable Hepatocellular Carcinoma and ... - Cancer Therapy Advisor PDF Print

Cancer Therapy Advisor

NEXAVAR (sorafenib) for Unresectable Hepatocellular Carcinoma and ...
Cancer Therapy Advisor
This slideshow reviews drug information for NEXAVAR (sorafenib), indicated for unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Table of Contents Slide 3: Indication, Dosage, and Administration Slide 7: Use in Specific Populations

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.